78252-11-6

Basic information

• Product Name: 2-Morpholino-5-nitrobenzonitrile
• Synonyms: 2-Morpholino-5-nitrobenzonitrile;2-(4-Morpholinyl)-5-nitrobenzonitrile
• CAS NO: 78252-11-6
• Molecular Formula: C₁₁H₁₁N₃O₃
• Molecular Weight: 233.22334
• Mol File: 78252-11-6.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Morpholino-5-nitrobenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Morpholino-5-nitrobenzonitrile(78252-11-6)
• EPA Substance Registry System: 2-Morpholino-5-nitrobenzonitrile(78252-11-6)

Safety Data

• Hazardous Substances Data: 78252-11-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Morpholino-5-nitrobenzonitrile is utilized as a key intermediate in the synthesis of pharmaceuticals. Its unique structure allows it to be a building block for the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Organic Chemistry:
In the realm of organic chemistry, 2-Morpholino-5-nitrobenzonitrile serves as a valuable intermediate for the synthesis of a range of organic compounds. Its reactivity and structural features make it suitable for various organic reactions, facilitating the creation of complex molecules.
Used in Dye and Pigment Production:
2-Morpholino-5-nitrobenzonitrile is employed in the production of dyes and pigments, where its chemical properties contribute to the color and stability of these products. Its use in this industry highlights its versatility and importance in creating a wide array of colorants for various applications.
Used in Industrial Chemicals:
2-Morpholino-5-nitrobenzonitrile also finds its place in the production of other industrial chemicals, where it may be used to enhance the properties of these chemicals or to serve as a component in their synthesis. Its role in this sector underscores its broad applicability across different areas of the chemical industry.
It is important to handle 2-Morpholino-5-nitrobenzonitrile with care due to its potential hazards, ensuring that safety protocols are followed to mitigate any risks associated with its reactivity.

Upstream product

• 110-91-8 morpholine 
• 134604-07-2 2-bromo-5-nitrobenzonitrile 
• 2516-96-3 2-chloro-5-nitrobenzoic acid 
• 16588-15-1 2-chloro-5-nitro-benzamide 
• 16588-02-6 4-chloro-3-cyanonitrobenzene 
• 17417-09-3 2-fluoro-5-nitrobenzonitrile 

Downstream Products

• 78252-12-7 5-amino-2-morpholin-4-yl-benzonitrile 

Relevant articles and documents

Design and synthesis of muscarinic acetylcholine receptor (mAChR) antagonist: pharmacophore-based screening and structure-based optimization

Abstract: This study describes screening of muscarinic acetylcholine receptors (mAChR) antagonist by pharmacophore modeling and optimization by molecular docking. A series of molecules was synthesized and evaluated for preliminary pharmacological activity

N-benzyl-N-aryl sulfonamide derivative as well as preparation and application thereof

The invention provides an N-Benzyl-N-Aryl sulfonamide derivative, wherein the N-Benzyl-N-Aryl sulfonamide derivatives include pharmaceutically acceptable salts and/or solvates thereof. The N-Benzyl-N-Aryl sulfonamide derivatives is obtained by condensatio

PROTEIN KINASE C INHIBITORS AND USES THEREOF

This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to ph

THERAPEUTIC CHROMONE COMPOUNDS

Provided herein is a compound of the formula (I) wherein said compound is useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating, disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B antagonists. Also provided herein are processes for making compounds of Formula (I) and intermediate compounds.

Therapeutic chroman compounds

Provided herein is a compound represented by the Formula (I) wherein said compounds are useful for the treatment of migraine. Also provided are processes for the preparation of compounds of Formula (I) and intermediates.

Therapeutic heterocyclic compounds

Provided herein is a compound having the formula (I): Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.

AMIDE COMPOUNDS AND MEDICINAL USE THEREOF

The present invention relates to a compound of the formula wherein R1 is substituted aryl, heteroaryl and the like, R2 and R3 are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X' is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.

The Origins of the Dichotomy of Amine Effects in Aromatic Nucleophilic Substitution Reactions

The reactions of 2-trifluoromethyl- amd 2-cyano-4-nitrofluoro-benzenes with piperidine, n-butylamine and benzylamine in acetonitrile are not base catalysed, but the reactions with morpholine are catalysed.In benzene, the reactions of the 2-cyano-substrate